Search for: "In re: Levaquin Products Liability Litigation" Results 1 - 19 of 19
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Nov 2010, 10:57 am by Tom Lamb
Tunheim, who is presiding over the federal court Levaquin multi-district litigation, or MDL -- known as In re: LEVAQUIN PRODUCTS LIABILITY LITIGATION, MDL No. 08-1943, pending in Minneapolis, Minnesota -- selected six cases from the 300 filed lawsuits in the Levaquin MDL (at that time) to be the so-called "bellwether", or test, cases. [read post]
1 Mar 2010, 1:56 pm by Tom Lamb
Tunheim received an update about the number of lawsuits in the federal court multi-district litigation, or MDL -- known as In re: LEVAQUIN PRODUCTS LIABILITY LITIGATION, MDL No. 08-1943 (JRT) -- and in certain state courts around the country. [read post]
27 Jan 2012, 8:59 am
Johnson & Johnson (JNJ), 08-05742, combined for trial in In re Levaquin Products Liability Litigation, 08- md-01943, U.S. [read post]
16 Nov 2010, 10:57 am by brettb
Johnson & Johnson, 08-cv-05743, combined for trial in In Re: Levaquin Products Liability Litigation, 08-md-01943, U.S. [read post]
6 Jan 2010, 3:10 am by Sean Wajert
 In re Levaquin Products Liability Litigation, MDL No. 08-1943, (D. [read post]
14 Feb 2012, 11:50 am by Michelle Yeary
Contact Lens Solution Products Liability Litigation (no website)MDL-1836 IN RE Mirapex Products Liability Litigation But, some are still going strong and may well continue to generate law that we report on here:MDL-1355 IN RE Propulsid Products Liability Litigation MDL-1507 IN RE Prempro Products Liability Litigation MDL-1789 IN RE Fosamax Products… [read post]
2 Dec 2010, 2:43 pm by Bexis
  Thus, we disagree with the decision in In re Levaquin Products Liability Litigation, 2010 U.S. [read post]
22 Dec 2010, 12:39 pm by Bexis
In re Gadolinium-Based Contrast Agents Products Liability Litigation, 2010 WL 1796334 (N.D. [read post]
5 Jul 2013, 5:00 am by Bexis
  Thus, in In re Zyprexa Products Liability Litigation, 489 F. [read post]
30 Jun 2011, 5:00 am by Bexis
  In re Heparin Product Liability Litigation, 2011 WL 1059660, at *9 (N.D. [read post]
5 Sep 2013, 12:24 pm by Bexis
June 1, 2012); In re Avandia Marketing, Sales Practices & Products Liability Litigation, 817 F. [read post]
7 Jan 2010, 10:36 am by Beck, et al.
” In re Orthopedic Bone Screw Products Liability Litigation, 1995 WL 428683, at *1-2 (E.D. [read post]
29 Dec 2010, 12:54 pm by Bexis
  Stick a fork in economic loss class actions derivative of supposed product liability defects – they’re done. [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation (IP Law Observer) Lescol (Fluvastatin) - US: Mylan confirms first-to-file patent challenge to Lescol by Novartis (SmartBrief) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd… [read post]
12 Mar 2024, 12:46 pm by admin
Moye from giving such testimony); In re Rezulin Products Liab. [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges Oxytrol patent… [read post]
16 Dec 2010, 1:54 pm by Bexis
  All of these questions would impact liability and/or damages. [read post]
11 Jul 2008, 4:30 am
Part I – Spicy IP), India: Discussion of grant of Indian patents to Cipla for Fosamax derivative and Nexium derivative: (Spicy IP), India: Draft National Biotechnology Regulatory Authority Bill: (Spicy IP), Ivory Coast: Ivorians increasingly choose fake medicines on price: (Afro-IP), Mexico: New Mexican medicaments approvals regime: an early report: (IP tango), UK: Leave to appeal refused in trade mark infringement proceedings between Eli Lilly and 8PM Chemist concerning the importation of… [read post]